Endoscopic Ultrasound-Guided Celiac Plexus Neurolysis (EUS-CPN) for Chronic Pancreatitis
Part of paid clinical trials in Indianapolis, Indiana.
- Sponsor
- Indiana University
- Study ID
- NCT04403074
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Celiac Plexus Neurolysis — PROCEDUREWhen CPBs are not effective (less than one month of relief) then a Celiac Plexus Neurolysis may be completed to manage pain associated with Chronic Pancreatitis.
Study Details
Physicians need a tracking system for specific treatment modalities, and data to determine the impact of endoscopic ultrasound pain management for patients with chronic pancreatitis.
Key Dates
- Start date
- Oct 20, 2017
- Status verified
- Feb 2026
- Primary completion
- Oct 20, 2029
- Completion
- Oct 20, 2029
Study Design
- Enrollment
- 35 participants (estimated)
Arms
- Arm: Chronic Pancreatitis PatientsPatients that have Chronic Pancreatitis and the current treatment with Celiac Plexus Blocks (CPB) are providing minimal relief of pain (CPB provide less than one month of pain relief). These patient will then receive a Celiac Plexus Neurolysis.
Primary Outcome Measure
Use of Pain medication [ Time Frame: Immediately post procedure & weekly up to 24 weeks ]
Central Contacts
- Mohammad Al-Haddad3179440980
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Indiana University Hospital | Indianapolis | Indiana | 46202 |
Find similar trials in Indianapolis, IN
By research site
Related Studies
- Evaluation of a Mixed Meal Test for Diagnosis and Characterization and Type 3c Diabetes Mellitus Secondary to Pancreatic Cancer and Chronic Pancreatitis (DETECT)Recruiting · M.D. Anderson Cancer Center · Los Angeles, California
- Pancreatic Quantitative Sensory Testing (P-QST) to Predict Treatment Response for Pain in Chronic PancreatitisRecruiting · University of Pittsburgh · Indianapolis, Indiana
- Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 StudyRecruiting · M.D. Anderson Cancer Center · Los Angeles, California
- Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic DisordersRecruiting · Mayo Clinic · Phoenix, Arizona